Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1136/vr.g5422 | DOI Listing |
Vet Rec
September 2014
VMD, Pharmacovigilance Unit, Woodham Lane, New Haw, Addlestone, Surrey KT15 3LS.
J Vet Pharmacol Ther
October 2014
Drug-Consult.Net, Magdeburg, Germany.
Imepitoin is a novel anti-epileptic licensed in the European Union for the treatment of canine idiopathic epilepsy. The aim of this study was to characterize the pharmacokinetics of imepitoin in dogs and to evaluate the interaction with drug metabolizing enzymes. Upon administration of imepitoin tablets at a dose of 30 mg/kg to beagle dogs, high plasma levels were observed within 30 min following oral dosing, with maximal plasma concentrations of 14.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!